drugset / Trial / NCT02322606
A Phase 1, Single and Multiple Dose Study of TAK-137
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics of TAK-137 in healthy male subjects.
Timeline
- Start
- 2014-11
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAK-137 | Unknown | 2 mg | Oral |
| Subject | TAK-137 | Unknown | 5 mg | Oral |
| Subject | TAK-137 | Unknown | 10 mg | Oral |
| Subject | TAK-137 | Unknown | 15 mg | Oral |
| Subject | TAK-137 | Unknown | 20 mg | Oral |
Indications
No indication recorded.